FDA Adverse Event Injury Summary report: N

PROLENE POLYPROPYLENE SUTURE UNKNOWN PRODUCT

MDR report key: 7603125 · Received June 14, 2018

Report

Report Number
2210968-2018-73488
Event Type
Injury
Date Received
June 14, 2018
Report Date
June 4, 2018
Manufacturer
ETHICON INC.
Product Code
GAW
PMA / PMN Number
K133356
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THIS REPORT IS RELATED TO A JOURNAL ARTICLE, THEREFORE NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. NO SPECIFIC PATIENT INFORMATION REGARDING EVENTS HAS BEEN PROVIDED. ATTEMPTS ARE BEING MADE TO OBTAIN THE FOLLOWING INFORMATION. IF FURTHER DETAILS ARE RECEIVED AT THE LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. DOES THE SURGEON BELIEVE THAT THE ETHICON PRODUCT INVOLVED CAUSED AND/OR CONTRIBUTED TO THE POSTOPERATIVE COMPLICATIONS DESCRIBED IN THE ARTICLE ? DOES THE SURGEON BELIEVE THERE WAS ANY DEFICIENCY WITH THE ETHICON SUTURE PRODUCT PROLENE USED IN THIS PROCEDURE? CITATION: INTERACT CARDIOVASC THORAC SURG 2015;20:707¿11; DOI:10.1093/ICVTS/IVV065. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED VIA JOURNAL ARTICLE TITLE: IS MINIMALLY INVASIVE MITRAL VALVE REPAIR WITH ARTIFICIAL CHORDS REPRODUCIBLE AND APPLICABLE IN ROUTINE SURGERY? AUTHOR(S): ARISTOTELIS PANOS, SYLVIO VLAD, FOTIOS MILAS AND PATRICK O. MYERS CITATION: INTERACT CARDIOVASC THORAC SURG 2015;20:707¿11; DOI:10.1093/ICVTS/IVV065 THE PURPOSE OF THIS RETROSPECTIVE STUDY WAS TO REVIEW THE EFFECTIVENESS AND REPRODUCIBILITY OF NEOCHORDAL REPAIR AS A ROUTINE APPROACH TO MINIMALLY INVASIVE MITRAL REPAIR, AND TO ASSESS THE STABILITY OF NEOCHORD IMPLANTATION USING THE FIGURE-OF-EIGHT SUTURE WITHOUT PLEDGETS IN THIS SETTING. BETWEEN 2008 AND 2013, 426 PATIENTS (AGE OF 55±18 YEARS) WHO UNDERWENT VIDEO-ASSISTED MITRAL VALVE REPAIR FOR DEGENERATIVE DISEASE OR HEALED ENDOCARDITIS OF THE POSTERIOR, ANTERIOR OR BOTH LEAFLETS. IN THE PROCEDURE, EPTFE CV 4/0 WAS USED AS PREFORMED LOOPS WHICH WERE ANCHORED IN THE ADEQUATE PAPILLARY MUSCLE (PM) BY A FIGURE-OF-EIGHT SUTURE, WITHOUT TEFLON FELT OR PLEDGETS, AND THEN ATTACHED TO THE LEAFLET FREE MARGIN BY MEANS OF AN EPTFE CV 6/0 (GORE) OR PROLENE 5/0 SUTURE. ONE PATIENT DIED WITHIN 30 DAYS OF MITRAL VALVE OPERATION. FIVE PATIENTS (1.1%) REQUIRED RE-EXPLORATION FOR BLEEDING (DECIDED ON THE BASIS OF >500 ML BLEEDING DURING THE FIRST HOUR DESPITE CORRECTION OF COAGULOPATHY) AND HAEMOSTASIS WAS ACHIEVED THROUGH THE SAME INCISION IN ALL OF THEM. NO VASCULAR OR WOUND COMPLICATIONS WERE OBSERVED. NO PATIENT REQUIRED REOPERATION DURING LATE FOLLOW-UP, AND THERE WERE NO LATE THROMBOEMBOLIC EVENTS. IN THE STUDY, THE SURGEONS DID NOT ENCOUNTER ANY DEHISCENCE OF THE MUSCLE DUE TO THE ABSENCE OF PLEDGETS. A FIGURE-OF-EIGHT EPTFE SUTURE PLACED IN A WIDE ANGLE AT THE ANATOMICAL CHORD POSITION (TIP OF THE PM) WITHOUT PLEDGETS FULFILS THE PHYSIOLOGICAL NEEDS AND TECHNICAL REQUIREMENTS FOR EXCELLENT LONG-TERM CLINICAL RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
445366 PROLENE POLYPROPYLENE SUTURE UNKNOWN PRODUCT SUTURE, NONABSORBABLE GAW ETHICON INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention